Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C30H29N5O4S.ClH |
Molecular Weight | 592.108 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 2 / 2 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.[H][C@]12CN(CCCCN3C(=O)NC4=C(SC5=C4N=C(C=N5)C6=CC=CC=C6)C3=O)C[C@@]1([H])C7=C(OC2)C=CC=C7OC
InChI
InChIKey=OFPMGRPQOZABPO-GZJHNZOKSA-N
InChI=1S/C30H29N5O4S.ClH/c1-38-22-10-7-11-23-24(22)20-16-34(15-19(20)17-39-23)12-5-6-13-35-29(36)27-25(33-30(35)37)26-28(40-27)31-14-21(32-26)18-8-3-2-4-9-18;/h2-4,7-11,14,19-20H,5-6,12-13,15-17H2,1H3,(H,33,37);1H/t19-,20-;/m1./s1
Molecular Formula | ClH |
Molecular Weight | 36.461 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Molecular Formula | C30H29N5O4S |
Molecular Weight | 555.647 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 2 / 2 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Originator
Approval Year
Sample Use Guides
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/11805207
Fiduxosin had higher affinity for cloned human alpha(1a)- (0.16 nM) and alpha(1d)-adrenoceptors (0.92 nM) in radioligand binding studies compared with alpha(1b)-adrenoceptors (25 nM).
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 16:25:01 GMT 2023
by
admin
on
Fri Dec 15 16:25:01 GMT 2023
|
Record UNII |
UYV23L1N89
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C29713
Created by
admin on Fri Dec 15 16:25:01 GMT 2023 , Edited by admin on Fri Dec 15 16:25:01 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
C81371
Created by
admin on Fri Dec 15 16:25:01 GMT 2023 , Edited by admin on Fri Dec 15 16:25:01 GMT 2023
|
PRIMARY | |||
|
LL-04
Created by
admin on Fri Dec 15 16:25:01 GMT 2023 , Edited by admin on Fri Dec 15 16:25:01 GMT 2023
|
PRIMARY | |||
|
DTXSID1049013
Created by
admin on Fri Dec 15 16:25:01 GMT 2023 , Edited by admin on Fri Dec 15 16:25:01 GMT 2023
|
PRIMARY | |||
|
208992-74-9
Created by
admin on Fri Dec 15 16:25:01 GMT 2023 , Edited by admin on Fri Dec 15 16:25:01 GMT 2023
|
PRIMARY | |||
|
CHEMBL1256183
Created by
admin on Fri Dec 15 16:25:01 GMT 2023 , Edited by admin on Fri Dec 15 16:25:01 GMT 2023
|
PRIMARY | |||
|
UYV23L1N89
Created by
admin on Fri Dec 15 16:25:01 GMT 2023 , Edited by admin on Fri Dec 15 16:25:01 GMT 2023
|
PRIMARY | |||
|
172306
Created by
admin on Fri Dec 15 16:25:01 GMT 2023 , Edited by admin on Fri Dec 15 16:25:01 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> SALT/SOLVATE |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |